MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma.

MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma.

Microtubule inhibitors have been shown to inhibit Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signal transduction pathway in various cancer cells. However, little is known of the mechanism by which the microtubule inhibitors inhibit STAT3 activity. In the present s...

Full description

Bibliographic Details
Main Authors:	Hsuan-Yu Peng, Yun-Ching Cheng, Yuan-Ming Hsu, Guan-Hsun Wu, Ching-Chuan Kuo, Jing-Ping Liou, Jang-Yang Chang, Shiow-Lian Catherine Jin, Shine-Gwo Shiah
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4930189?pdf=render

Similar Items

Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma
by: I-Ting Tsai, et al.
Published: (2018-03-01)

Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
by: Xilan Yang, et al.
Published: (2020-03-01)

The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology
by: Natalie A. Sims
Published: (2020-08-01)

The molecular basis of JAK/STAT inhibition by SOCS1
by: Nicholas P. D. Liau, et al.
Published: (2018-04-01)

Prmt7 regulates the JAK/STAT/Socs3 signaling pathway in postmenopausal cardiomyopathy
by: Byeong-Yun Ahn, et al.
Published: (2024-03-01)

The Effect of Valproic Acid Drug on the Expression of SOCS1, SOCS3, JAK1, JAK2, STAT3, STAT5A and STAT5B Genes in HepG2 Cell Line Liver Cancer
by: M Sanai Jahormi, et al.
Published: (2022-04-01)

TARGETED ANALYSIS OF JAK-STAT-SOCS GENES IN DAIRY CATTLE
by: Arun Sondur Jayappa, et al.
Published: (2015-12-01)

The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway
by: Xianwei Han, et al.
Published: (2023-01-01)

miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
by: Aideen S Collins, et al.
Published: (2013-01-01)

A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway.
by: Nai-Jung Chiang, et al.
Published: (2013-01-01)

MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking
by: Hsuan-Yu Peng, et al.
Published: (2020-11-01)

t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5.
by: Stefan Ehrentraut, et al.
Published: (2013-01-01)

PEGylated SOCS3 Mimetics Encapsulated into PLGA-NPs as Selective Inhibitors of JAK/STAT Pathway in TNBC Cells
by: La Manna S, et al.
Published: (2024-07-01)

Inhibition of the SOCS1-JAK2-STAT3 Signaling Pathway Confers Neuroprotection in Rats with Ischemic Stroke
by: Xiao-Lei Wang, et al.
Published: (2017-11-01)

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling
by: Ze-Kun Liu, et al.
Published: (2021-05-01)

SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
by: Rahul Pandey, et al.
Published: (2023-10-01)

Yishen Tongbi decoction attenuates inflammation and bone destruction in rheumatoid arthritis by regulating JAK/STAT3/SOCS3 pathway
by: Jia Xu, et al.
Published: (2024-06-01)

The role of JAK/STAT/SOCS3 signaling in rats with brain damage induced by early alcohol exposure after birth
by: Chen Yang, et al.
Published: (2024-06-01)

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
by: Spandana Rajendra Kopalli, et al.
Published: (2022-07-01)

Association analysis of SOCS3, JAK2 and STAT3 gene polymorphisms and genetic susceptibility to type 2 diabetes mellitus in Chinese population
by: Yang Zhang, et al.
Published: (2022-01-01)

LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway
by: Haoli Gong, et al.
Published: (2023-04-01)

LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway
by: Chuigong Yu, et al.
Published: (2022-07-01)

Protective effects of Isodon Suzhouensis extract and glaucocalyxin A on chronic obstructive pulmonary disease through SOCS3–JAKs/STATs pathway
by: Kefeng Zhai, et al.
Published: (2023-03-01)

Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling.
by: Lifeng Jia, et al.
Published: (2016-01-01)

Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the JAK2/STAT3 Signaling Pathway
by: Hongtao Luo, et al.
Published: (2020-11-01)

SOCS2 inhibits hepatoblastoma metastasis via downregulation of the JAK2/STAT5 signal pathway
by: Yong Lv, et al.
Published: (2023-12-01)

Curcumin Suppressed Activation of Dendritic Cells via JAK/STAT/SOCS Signal in Mice with Experimental Colitis
by: Hai-mei Zhao, et al.
Published: (2016-11-01)

Increased expression of STAT3 and SOCS3 in placenta from hyperglycemic rats
by: Vanessa Dela Justina, et al.
Published: (2019-10-01)

STAT3/SOCS3 axis contributes to the outcome of salmonid whirling disease.
by: Mona Saleh, et al.
Published: (2020-01-01)

STAT3 and SOCS3 expression patterns during murine placenta development
by: S. San Martin, et al.
Published: (2013-06-01)

Corrigendum: SOCS1/JAK2/STAT3 axis regulates early brain injury induced by subarachnoid hemorrhage via inflammatory responses
Published: (2025-03-01)

Wogonin upregulates SOCS3 to alleviate the injury in Diabetic Nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway
by: Yufeng Liu, et al.
Published: (2024-06-01)

METTL14-mediated m6A modification upregulated SOCS3 expression alleviates thyroid cancer progression by regulating the JAK2/STAT3 pathway
by: Ming Zhou, et al.
Published: (2024-12-01)

JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth
by: Malabika Sen, et al.
Published: (2015-03-01)

Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.
by: Hanan El-Abhar, et al.
Published: (2018-01-01)

Curcumin Regulates Anti-Inflammatory Responses by JAK/STAT/SOCS Signaling Pathway in BV-2 Microglial Cells
by: Chiara Porro, et al.
Published: (2019-06-01)

LINC00669 insulates the JAK/STAT suppressor SOCS1 to promote nasopharyngeal cancer cell proliferation and invasion
by: Xiang Qing, et al.
Published: (2020-08-01)

Shikonin attenuates rheumatoid arthritis by targeting SOCS1/JAK/STAT signaling pathway of fibroblast like synoviocytes
by: Lianhua He, et al.
Published: (2021-10-01)

Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.
by: Asma Beldi-Ferchiou, et al.
Published: (2017-01-01)

RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop
by: Chengwu Xiao, et al.
Published: (2022-05-01)